PeptidePicker
Home/Peptides/BPC-157
RecoveryCompounding

BPC-157

Also known as: Body Protection Compound 157 · PL 14736 · Pentadecapeptide

A synthetic 15-amino-acid peptide derived from gastric juice protein, studied for accelerating healing of tendons, muscles, ligaments, and gut tissue. The most-searched research peptide globally.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~4 hours

Typical Dose

250–500 mcg

Administration

Subcutaneous injection or oral

Mechanism of Action

Promotes angiogenesis, modulates nitric oxide pathways, upregulates growth factor expression, and stimulates tendon fibroblast migration to accelerate tissue repair.

Key Research Areas

healingrecoverygut healthtendoninjury

Frequently Asked Questions

What is BPC-157?
A synthetic 15-amino-acid peptide derived from gastric juice protein, studied for accelerating healing of tendons, muscles, ligaments, and gut tissue. The most-searched research peptide globally.
How does BPC-157 work?
Promotes angiogenesis, modulates nitric oxide pathways, upregulates growth factor expression, and stimulates tendon fibroblast migration to accelerate tissue repair.
What is the recommended dosage for BPC-157?
The typical research dosage is 250–500 mcg, administered via Subcutaneous injection or oral. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of BPC-157?
The half-life of BPC-157 is approximately ~4 hours. This affects dosing frequency and timing in research protocols.
Is BPC-157 FDA approved?
BPC-157 is currently classified as "Compounding" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Research Disclaimer

The information provided about BPC-157 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Recovery